BR9814136A - Conjunto contraceptivo, processos de fabricação do mesmo e de tratamento de sangramento, usos de anti-progestogênio, de progestogênio e de anti-progestogênio, e, de um composto. - Google Patents
Conjunto contraceptivo, processos de fabricação do mesmo e de tratamento de sangramento, usos de anti-progestogênio, de progestogênio e de anti-progestogênio, e, de um composto.Info
- Publication number
- BR9814136A BR9814136A BR9814136-8A BR9814136A BR9814136A BR 9814136 A BR9814136 A BR 9814136A BR 9814136 A BR9814136 A BR 9814136A BR 9814136 A BR9814136 A BR 9814136A
- Authority
- BR
- Brazil
- Prior art keywords
- progestin
- contraceptive
- progestogen
- compound
- manufacturing processes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Abstract
''CONJUNTO CONTRACEPTIVO, PROCESSOS DE FABRICAçãO DO MESMO E DE TRATAMENTO DE SANGRAMENTO, USOS DE ANTI-PROGESTOGêNIO, DE PROGESTOGêNIO E DE ANTI-PROGESTOGêNIO, E, DE UM COMPOSTO" Um contraceptivo isento de estrogênio é provido, que não tem os inconvenientes relacionados com sangramento de pílulas somente progestogênio convencionais. Assim, a invenção é um conjunto contraceptivo compreendendo um meio combinado para a administração diária simultânea de um progestogênio como o único ingrediente efetivo contraceptivamente, e um anti-progestogênio. O referido meio combinado preferivelemente está na forma de comprimidos tendo uma dose contraceptiva normal de progestogênio e uma baixa dose de anti-progestogênio.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97203543 | 1997-11-14 | ||
| EP98201464 | 1998-05-08 | ||
| PCT/EP1998/007221 WO1999025360A2 (en) | 1997-11-14 | 1998-11-10 | Progestogen-antiprogestogen regimens |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9814136A true BR9814136A (pt) | 2000-10-03 |
Family
ID=26147039
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9814136-8A BR9814136A (pt) | 1997-11-14 | 1998-11-10 | Conjunto contraceptivo, processos de fabricação do mesmo e de tratamento de sangramento, usos de anti-progestogênio, de progestogênio e de anti-progestogênio, e, de um composto. |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US6642219B1 (pt) |
| EP (1) | EP1030669A2 (pt) |
| JP (1) | JP2001523639A (pt) |
| KR (1) | KR20010032056A (pt) |
| CN (1) | CN1281363A (pt) |
| AU (1) | AU747710B2 (pt) |
| BR (1) | BR9814136A (pt) |
| CA (1) | CA2309745A1 (pt) |
| HU (1) | HUP0100542A3 (pt) |
| NO (1) | NO20002475L (pt) |
| NZ (1) | NZ504351A (pt) |
| PL (1) | PL341087A1 (pt) |
| RU (1) | RU2215540C2 (pt) |
| TR (1) | TR200001334T2 (pt) |
| WO (1) | WO1999025360A2 (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6756366B1 (en) * | 1999-04-06 | 2004-06-29 | Akzo Nobel N.V. | Orally active androgens |
| EP1482949A1 (en) * | 2002-03-11 | 2004-12-08 | Janssen Pharmaceutica N.V. | Sulfatase inhibiting progestogen-only contraceptive regimens |
| CA2478206A1 (en) * | 2002-03-11 | 2003-09-25 | Patrick Michel Caubel | Sulfatase inhibiting continuous progestogen contraceptive regimens |
| TW200531977A (en) | 2004-03-25 | 2005-10-01 | Akzo Nobel Nv | Progesterone receptor modulators |
| CN101370550B (zh) * | 2006-01-19 | 2012-08-29 | Msd欧斯股份有限公司 | 组装用于插入植入物的操作器的器械包和方法 |
| US8299050B2 (en) * | 2008-01-29 | 2012-10-30 | Laboratoire Hra-Pharma | Method for treating uterine fibroids |
| WO2022207631A1 (en) * | 2021-03-29 | 2022-10-06 | Cemag Care | Methods for providing late luteal contraception |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2552125B1 (fr) | 1983-09-16 | 1986-03-21 | Interox | Procede pour le taitement des matieres cellulosiques par des agents oxydants |
| US4847089A (en) | 1986-07-16 | 1989-07-11 | David N. Kramer | Cleansing and distinfecting compositions, including bleaching agents, and sponges and other applicators incorporating the same |
| US4855305A (en) | 1987-03-23 | 1989-08-08 | Applied Medical Research | Compositions and methods of effecting contraception utilizing melatonin |
| DE3729442A1 (de) | 1987-09-03 | 1989-03-23 | Wfk Testgewebe Gmbh | Verfahren zum bleichen und/oder desinfizieren von textilen flaechengebilden in einer waschmaschine |
| SE8801373D0 (sv) | 1988-04-14 | 1988-04-14 | Akerlund & Rausing Ab | Forfarande for sterilisering av forpackningsmaterial, forpackningsbehallare eller delar till sadana samt anordning for genomforande av forfarandet |
| US5871702A (en) | 1988-04-21 | 1999-02-16 | Flexiclave, Inc. | Methods and apparatus for sterilizing objects |
| US5320805A (en) | 1991-05-15 | 1994-06-14 | Sterilex Corporation | Methods of using a cleaner, sanitizer, disinfectant, fungicide, sporicide, chemical sterilizer |
| ZA929315B (en) | 1991-12-20 | 1993-05-24 | Akzo Nv | 17-spirofuran-3'-ylidene steroids. |
| MX9301121A (es) | 1992-03-02 | 1993-09-01 | Schering Ag | Metodo y equipo para la contracepcion oral y regulacion de la menstruacion con estrogeno/progestina/aniprogestina. |
| WO1993021926A1 (en) * | 1992-05-06 | 1993-11-11 | Medical College Of Hampton Roads | Minimizing progestin associated breakthrough bleeding |
| ZA935617B (en) * | 1992-08-14 | 1994-03-07 | Akzo Nv | Antiprogestogen containing contraceptives. |
| DE4308406C1 (de) | 1993-03-12 | 1994-06-16 | Jenapharm Gmbh | Kombinationspräparat zur Kontrazeption |
| DE4330234A1 (de) * | 1993-09-02 | 1995-03-09 | Schering Ag | Verwendung von Gestagenen und kompetitiven Progesteronantagonisten zur Herstellung von Arzneimitteln für die weibliche Fertilitätskontrolle sowie Mittel enthaltend ein Gestagen und einen kompetitiven Progesteronantagonisten |
| DE4344463A1 (de) * | 1993-12-22 | 1995-06-29 | Schering Ag | Kombinationsprodukt zur Kontrazeption |
| DE4426601A1 (de) | 1994-07-27 | 1996-02-01 | Schering Ag | Verwendung eines Kombinationsproduktes enthaltend einen kompetitiven Progesteronantagonisten und ein Gestagen zur Herstellung eines Arzneimittels zur Behandlung der Endometriose oder des Leiomyomata uteri |
| EP0792152B1 (en) * | 1994-11-22 | 2004-04-14 | Balance Pharmaceuticals, Inc. | Methods of contraception |
| US5521166A (en) | 1994-12-19 | 1996-05-28 | Ortho Pharmaceitical Corporation | Antiprogestin cyclophasic hormonal regimen |
| DE19531936A1 (de) * | 1995-08-17 | 1997-02-20 | Schering Ag | Kombinationspräparat zur Kontrazeption, Kits diese enthaltend und eine Methode diese verwendend |
| RU2189819C2 (ru) | 1996-06-25 | 2002-09-27 | Акцо Нобель Н.В. | Схемы приема прогестогена-антипрогестогена |
| AU3661897A (en) | 1996-07-24 | 1998-02-10 | Procter & Gamble Company, The | Method for stain removal on hard surfaces with detergent compositions containing bleach |
| JPH11514037A (ja) | 1996-07-24 | 1999-11-30 | ザ、プロクター、エンド、ギャンブル、カンパニー | 漂白剤を活性化する方法 |
-
1998
- 1998-11-10 RU RU2000115313/14A patent/RU2215540C2/ru not_active IP Right Cessation
- 1998-11-10 BR BR9814136-8A patent/BR9814136A/pt not_active IP Right Cessation
- 1998-11-10 AU AU21527/99A patent/AU747710B2/en not_active Ceased
- 1998-11-10 EP EP98965666A patent/EP1030669A2/en not_active Withdrawn
- 1998-11-10 TR TR2000/01334T patent/TR200001334T2/xx unknown
- 1998-11-10 HU HU0100542A patent/HUP0100542A3/hu unknown
- 1998-11-10 NZ NZ504351A patent/NZ504351A/xx unknown
- 1998-11-10 KR KR1020007005177A patent/KR20010032056A/ko not_active Application Discontinuation
- 1998-11-10 CN CN98812039A patent/CN1281363A/zh active Pending
- 1998-11-10 CA CA002309745A patent/CA2309745A1/en not_active Abandoned
- 1998-11-10 WO PCT/EP1998/007221 patent/WO1999025360A2/en not_active Application Discontinuation
- 1998-11-10 PL PL98341087A patent/PL341087A1/xx unknown
- 1998-11-10 JP JP2000520793A patent/JP2001523639A/ja not_active Withdrawn
- 1998-11-11 US US09/554,429 patent/US6642219B1/en not_active Expired - Fee Related
-
2000
- 2000-05-12 NO NO20002475A patent/NO20002475L/no unknown
-
2003
- 2003-03-14 US US10/389,506 patent/US20030176404A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999025360A3 (en) | 1999-07-29 |
| CN1281363A (zh) | 2001-01-24 |
| TR200001334T2 (tr) | 2000-09-21 |
| HUP0100542A2 (hu) | 2001-08-28 |
| EP1030669A2 (en) | 2000-08-30 |
| JP2001523639A (ja) | 2001-11-27 |
| CA2309745A1 (en) | 1999-05-27 |
| HUP0100542A3 (en) | 2001-10-29 |
| RU2215540C2 (ru) | 2003-11-10 |
| PL341087A1 (en) | 2001-03-26 |
| WO1999025360A2 (en) | 1999-05-27 |
| NZ504351A (en) | 2002-10-25 |
| US20030176404A1 (en) | 2003-09-18 |
| AU747710B2 (en) | 2002-05-23 |
| US6642219B1 (en) | 2003-11-04 |
| NO20002475L (no) | 2000-07-12 |
| AU2152799A (en) | 1999-06-07 |
| NO20002475D0 (no) | 2000-05-12 |
| KR20010032056A (ko) | 2001-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2174920T3 (es) | Producto de combinacion para la contracepcion que contiene agentes antagonistas de progesterona y un agente gestageno. | |
| AR013614A1 (es) | Nueva composicion que comprende una combinacion de esteroides, un kit que la contiene, el uso de la misma, el uso de dicho kit de formoterol y debudesonida en la fabricacion de un medicamento | |
| DK1011682T3 (da) | Hormonalt antikonceptionsmiddel | |
| BR0109912A (pt) | Novas combinações antelmìnticas | |
| CA2188907A1 (en) | Combination compound for contraception based on natural estrogen | |
| ES2182357T3 (es) | Nueva utilizacion de budesonide y formoterol. | |
| UA37259C2 (uk) | Активна речовина для одержання лікарських засобів при лікуванні дисфункціональних маткових кровотеч | |
| ES2174629T3 (es) | 14,15-ciclopropano-esteroides de la serie de los 19-nor-androstanos, procedimiento para su preparacion y formulaciones farmaceuticas que contienen estos compuestos. | |
| DK0402950T3 (da) | Behandling af postmenopausale ulemper | |
| AR011480A1 (es) | ACIL-ANILIDAS SUSTITUIDAS CON RADICALES (HETERO) CICLICOS, NO ESTEROIDALES, CON ACTIVIDAD GESTÁGENA Y ANDRoGENA MIXTA. | |
| ITMI961152A0 (it) | Composizione terapeutica per la somministrazione transdermica di un principio attivo estrogeno o progestinico o di loro miscele | |
| HUP0004133A3 (en) | Combined use of progestin and polycarboxilic acid for the preparation of pharmaceutical compositions for controlled bleeding | |
| CO5631449A2 (es) | Nuevos esteres de etonogestrel | |
| BR9913457A (pt) | Neuroproteção | |
| BR9808140A (pt) | Formulação unitária | |
| KR890015742A (ko) | 이병치료용 국소 제제 | |
| BR9814136A (pt) | Conjunto contraceptivo, processos de fabricação do mesmo e de tratamento de sangramento, usos de anti-progestogênio, de progestogênio e de anti-progestogênio, e, de um composto. | |
| BR9811298A (pt) | Uso de um composto de vanádio fisiologicamente aceitável | |
| BG102682A (en) | System for the release of contraceptives having bactericidal and/or antiviral effect | |
| ES2162919T3 (es) | Piridilbisfosfonatos para uso como agente terapeutico. | |
| GR3025872T3 (en) | Orally active derivatives of 1,3,5(10)-estratriene | |
| BR9707770C1 (pt) | Tifluzamida com eficácia aperfeiçoada | |
| BR9908885A (pt) | Medicamento para a profilaxia e/ou tratamento de mastocarcinoma, compreendendo um inibidor esteróide de aromatase | |
| BR0015781A (pt) | Composição farmacêutica para tratamento de doenças associadas à diminuição de massa óssea | |
| BR9906862A (pt) | Uso de uma quantidade eficaz de um agente desubstituição hormonal para o tratamento demenopausa humana e de endometriose |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A,8A E 9A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1910 DE 14/08/2007. |